Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Mallinckrodt
McKinsey
Baxter
Boehringer Ingelheim

Last Updated: March 29, 2020

DrugPatentWatch Database Preview

DARAPRIM Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Daraprim patents expire, and what generic alternatives are available?

Daraprim is a drug marketed by Vyera Pharms Llc and is included in one NDA.

The generic ingredient in DARAPRIM is pyrimethamine. There are three drug master file entries for this compound. Additional details are available on the pyrimethamine profile page.

Drug patent expirations by year for DARAPRIM
Drug Prices for DARAPRIM

See drug prices for DARAPRIM

Recent Clinical Trials for DARAPRIM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Erasmus Medical CenterPhase 1/Phase 2
Albert Einstein College of MedicinePhase 1
Montefiore Medical CenterPhase 1

See all DARAPRIM clinical trials

Synonyms for DARAPRIM
057P350
2, 5-(4-chlorophenyl)-6-ethyl-
2, 5-(p-chlorophenyl)-6-ethyl-
2,4-diamino-5-(4-chloro-phenyl)-6-ethylpyrimidine
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine, 97%
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
2,4-diamino-5(4-chlorophenyl)-6-ethylpyrimidine
2,4-diamino-6-ethyl-5-(4-chlorophenyl)pyrimidine
2,4-Pyrimidinediamine, 5-(4-chlorophenyl)-6-ethyl-
2,4-Pyrimidinediamine, 5-(p-chlorophenyl)-6-ethyl-
2,4,-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
4753 r.p
4753 R.P.
4CH-018330
4km0
5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE
5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine
5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE
5-(4-chlorophenyl)-6-ethyl-pyrimidine-2,4-diamine
5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
58-14-0
A831755
AB00052084
AB00052084_22
AB00052084_25
AB00052084-21
AB0011152
AB02313
AB2000417
AC-7879
AI3-25005
AK-35735
AKOS015892534
ANW-44788
API0003994
AX8021591
AZT + Pyrimethamine combination
BDBM18512
BIDD:GT0149
BIDD:PXR0173
BPBio1_000147
BRD-9204
BRD-K88429204-001-05-4
BRD-K88429204-001-18-7
BRD-K88429204-001-21-1
BRD-K88429204-001-36-9
BRD9204
BRN 0219864
BSPBio_000133
BSPBio_003282
BW 50-63
BW 5063
C-36508
C07391
C12H13ClN4
CAS-58-14-0
CCG-39626
CCRIS 546
CHEBI:8673
CHEMBL36
Chloridin
Chloridine
Chloridyn
cid_4993
CP6
CPD000058714
CRL-8131 & Pyrimethamine
CRL-8142 & Pyrimethamine
CS-1717
CTK8B4350
D00488
Darachlor
Daraclor
Daraclor (Salt/Mix)
Darapram
Daraprim (TN)
Daraprim;Malocide; Pirimecidan
Daraprime
Daraprin
DB-053158
DB00205
Diaminopyritamin
DivK1c_000652
DSSTox_CID_1217
DSSTox_GSID_21217
DSSTox_RID_76016
DTXSID9021217
EINECS 200-364-2
Erbaprelina
Ethylpyrimidine
EXR-101
Fansidar (Pyrimethamine/Sulfadoxine)
FT-0631253
GNF-Pf-5586
GTPL4800
HMS1568G15
HMS1920N12
HMS2092E13
HMS2095G15
HMS2235A17
HMS3259C04
HMS3371L07
HMS3655D09
HMS3675P11
HMS3712G15
HMS3743O05
HMS502A14
HSDB 8042
HY-18062
IDI1_000652
KBio1_000652
KBio2_001386
KBio2_003954
KBio2_006522
KBio3_002502
KBioGR_001007
KBioSS_001386
Khloridin
KS-00000JIP
KS-5223
L000713
Lactoferrin B & Pyrimethamine
Lactoferrin H & Pyrimethamine
LS-238
LS40239
m alocid
M-1612
Malacid
Malocid
Malocide
Maloprim
MLS-0002822.0001
MLS000028606
MLS001148621
MLS002454446
MLS002701881
NC00528
NCGC00016256-01
NCGC00016256-02
NCGC00016256-03
NCGC00016256-04
NCGC00016256-05
NCGC00016256-06
NCGC00016256-07
NCGC00016256-08
NCGC00016256-09
NCGC00016256-10
NCGC00016256-11
NCGC00016256-12
NCGC00016256-13
NCGC00016256-14
NCGC00016256-16
NCGC00016256-17
NCGC00023188-03
NCGC00023188-04
NCGC00023188-05
NCGC00023188-06
NCGC00023188-07
NCGC00254199-01
NCGC00259383-01
NCI-C01683
NCI60_002604
NCIOpen2_008313
NINDS_000652
NSC 3061
NSC-3061
NSC-757306
NSC3061
NSC757306
Opera_ID_1437
P2037
Pharmakon1600-01500520
Pirimecidan
Pirimecidan;Pirimetamin;RP 4753
Pirimetamin
Pirimetamina
Pirimetamina [INN-Spanish]
Pirimetamina [Spanish]
Prestwick_504
Prestwick0_000037
Prestwick1_000037
Prestwick2_000037
Prestwick3_000037
Primethamine
PubChem9611
Pyremethamine
Pyrimethamin
pyrimethamine
Pyrimethamine (JAN/USP/INN)
Pyrimethamine (Pyr)
Pyrimethamine [USAN:INN:BAN:JAN]
Pyrimethamine [USP:INN:BAN:JAN]
Pyrimethamine, 98%
Pyrimethamine, European Pharmacopoeia (EP) Reference Standard
Pyrimethamine, United States Pharmacopeia (USP) Reference Standard
Pyrimethamine, VETRANAL(TM), analytical standard
Pyrimethaminum
Pyrimethaminum [INN-Latin]
Pyrimidine, 2,4-diamino-5-(p-chlorophenyl)-6-ethyl-
Pyrimidine,4-diamino-5-(p-chlorophenyl)-6-ethyl-
Q-201648
Q421072
RP 4753
RP-4753
S2006
SAM002554921
SBI-0051500.P003
SC-05503
SCHEMBL25129
SMR000058714
SPBio_000672
SPBio_002054
Spectrum_000906
SPECTRUM1500520
Spectrum2_000886
Spectrum3_001701
Spectrum4_000494
Spectrum5_001447
SR-01000003150
SR-01000003150-2
SR-01000003150-4
ST2406007
SW196698-3
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
Tox21_110332
Tox21_110332_1
Tox21_201834
Tox21_300129
TR-020233
UNII-Z3614QOX8W
WKSAUQYGYAYLPV-UHFFFAOYSA-N
WLN: T6N CNJ BZ DZ ER DG& F2
WR 2978
WR-2978
Z2065727768
Z3614QOX8W
ZINC57464

US Patents and Regulatory Information for DARAPRIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vyera Pharms Llc DARAPRIM pyrimethamine TABLET;ORAL 008578-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Mallinckrodt
McKinsey
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.